The diagnosis of a substance use or opioid use disorder during pregnancy is linked to complications for the mother, fetus, and newborn. Chronically drug exposed fetuses are at high risk for neonatal abstinence syndrome (NAS) or neonatal opioid withdrawal syndrome…
The diagnosis of a substance use or opioid use disorder during pregnancy is linked to complications for the mother, fetus, and newborn. Chronically drug exposed fetuses are at high risk for neonatal abstinence syndrome (NAS) or neonatal opioid withdrawal syndrome…
The overarching purpose of this training is to provide concentrated education and resources to promote the safe and effective prescribing of controlled substances when clinically appropriate for a legitimate medical purpose. The focus is to accelerate practice implementation and compliance…
Differences in clinical opinions regarding the interpretation of EFM data or other clinical factors between two perinatal practitioners can and will happen. Choosing not to share a clinical opinion when it is clinically indicated or refusing to take into consideration…
Differences in clinical opinions regarding the interpretation of EFM data or other clinical factors between two perinatal practitioners can and will happen. Choosing not to share a clinical opinion when it is clinically indicated or refusing to take into consideration…
© 2024
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
